Skip to main content
Figure 5 | BMC Medical Genetics

Figure 5

From: Pathogenic substitution of IVS15 + 5G > A in SLC26A4 in patients of Okinawa Islands with enlarged vestibular aqueduct syndrome or Pendred syndrome

Figure 5

Relative expression of the SLC26A4 gene in control subjects and in patients with a homozygous mutation of IVS15 + 5G > A or compound heterozygous mutation of IVS15 + 5G > A/H723R. The ratio of SLC26A4 mRNA to GAPDH mRNA is shown in three control subjects (A, B, C), three patients with compound heterozygous mutation of IVS15 + 5G > A/H723R (D, E, F), and three patients with IVS15 + 5G > A homozygous substitution (G, H, I). No expression of SLC26A4 was observed in the three patients with the IVS15 + 5G > A homozygous substitution (G, H, I). All experiments were done in tripricate.

Back to article page

BMC Medical Genetics

ISSN: 1471-2350

Contact us